We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Lonza Acquires Cell and Gene Contract Manufacturer PharmaCell

News   May 31, 2017 | Original Story from Lonza

 
Lonza Acquires Cell and Gene Contract Manufacturer PharmaCell
 
 
 

RELATED ARTICLES

Single-cell Analysis Opens Doors for Targeted Treatment in Autism Spectrum Disorder

News

Researchers have adopted single-cell analysis to uncover the molecular underpinnings of Autism Spectrum Disorder (ASD). Their findings may have implications for targeted therapeutics.

READ MORE

Broccoli Compound Restores Potent Cancer Cell Suppressor Function

News

Researchers report that indole-3-carbinol (I3C) – a natural compound found in broccoli – can be used to therapeutically target a gene (WWP1) known to play a role in several human cancers.

READ MORE

Antiviral Immunity Differs in Stem Cells

News

A discovery of how stem cells are protected from viruses could inform the development of therapies for use in medicine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE